Drugs / KL0011034
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07710560 | Jul 2026 overdue | chronic pain syndrome | Hunan Kelun Pharmaceutical Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07474545 | Mar 2026 → Dec 2027 expected | — | Hunan Kelun Pharmaceutical Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KL0011034 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07474545 ↗ |